Sunday, August 9, 2026

HomeHealth NewsFDA drug trials exclude a widening slice of Americans, research reveals

FDA drug trials exclude a widening slice of Americans, research reveals

- Advertisement -

Chart indicating declining representation for Black and Hispanic groups in clinical trials. Credit: Zaaijer, S., Groen, S.C. Communications Medicine

A new study finds just 6% of clinical trials used to approve new drugs in the U.S. reflect the country’s racial and ethnic makeup, with an increasing trend of trials underrepresenting Black and Hispanic individuals.

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed